INS and hyperinsulinism: In accordance with previous observations [41] we found that females meeting the NIH definition showed a more adverse metabolic risk profile with higher degree of abdominal adiposity and hyperinsulinemia, underlining the possible importance of insulin sensitizers in the clinical management of this subgroup.